Vanguard Group Inc Amphastar Pharmaceuticals, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,672,862 shares of AMPH stock, worth $134 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,672,862
Previous 2,734,040
2.24%
Holding current value
$134 Million
Previous $120 Million
10.94%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
34.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$298 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$97.4 Million0.19% of portfolio
-
Td Asset Management Inc1.69MShares$84.7 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$81.3 Million0.05% of portfolio
-
State Street Corp Boston, MA1.53MShares$76.6 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.46B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...